<DOC>
	<DOCNO>NCT00362518</DOCNO>
	<brief_summary>The propose study examine hypothesis vitamin C vitamin E give type 2 diabetic individual provide effective anti-inflammatory , anti-thrombotic , anti-oxidative atherosclerotic protection administer optimal dose determine surrogate marker inflammation , hypercoagulability , oxidation .</brief_summary>
	<brief_title>Vitamins C Vitamin E Cardiovascular Risk</brief_title>
	<detailed_description>This American Diabetes Association research project determine discrepant result individual study Vitamin E C animal human compare result obtain large randomized human trial use Vitamin E. Subjects : The study enroll subject ( men woman ) type 2 diabetes least six month duration . An outpatient screening test utilize following : complete history physical examination , EKG , urine hcG ( woman childbearing age ) , follow blood test : CBC , Chem-20 , lipid profile , hemoglobin A1C , C-peptide stimulation test . Subjects exclude know vascular disease , uncontrolled hypertension ( &gt; 140/90 mmHg ) mark hyperlipidemia ( serum low density lipoprotein &gt; 4.1 mmol/L serum triglyceride &gt; 7.8 mmol/L ) . Eligible patient must normal electrocardiogram tracing normal screen test result ( describe ) . Other important exclusion criterion cigarette smoking , volunteer take Coumadin , recent use antioxidant supplement aspirin . All patient provide write informed consent enrollment approve University New Mexico Human Research Review Committee . Surrogate Markers : Based preliminary data publish medical literature , extremely likely vitamin C E modify three contributor atherosclerosis : Oxidative stress , Hypercoagulability , Inflammation . Therefore , show table , include standard surrogate marker three contributor . Specific Aim : Determine optimal oral dose vitamin C vitamin E relative consumption atherogenic high fat supper type 2 diabetic individual . These data necessary order design prospective clinical trial vitamin give prevent delay atherosclerotic event . One reason publish clinical trial demonstrate conflict result may different dosage vitamin utilized . In follow study , utilize high fat ( simulate Big Mac ) meal assess beneficial effect vitamin surrogate marker atherosclerosis . Three dosage vitamin utilized order determine optimal dosage . The three dosage test 1 ) low dose - vitamin C 250mg , vitamin E 200 IU 2 ) medium dose - vitamin C 500 mg , vitamin E 400 IU 3 ) high dose - vitamin C 1000mg , vitamin E 800 IU . The result compare control meal study placebo ( hence , vitamin ) administer . The vitamin administer breakfast study day .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>The study enroll subject , men woman type 2 diabetes least six month duration . The age enrol subject range 2160 year old . An HbA1c blood test must show person 's diabetes control . Eligible subject must normal electrocardiogram tracing normal hematological , electrolyte liver laboratory result screen . Females childbearing age must agree use effective form birth control throughout study period . Subjects exclude know vascular disease , uncontrolled hypertension ( &gt; 140/90 mmHg ) , mark hyperlipidemia ( serum low density lipoprotein &gt; 4.1 mmol/L serum triglyceride &gt; 7.8 mmol/L ) , body mass index great 40 kg/m2 ( range 2740 ) . Other important exclusion criterion cigarette smoking , volunteer take Coumadin , recent use antioxidant supplement aspirin . Females pregnant breastfeeding exclude . People participate study take medication ( antidiabetic medication ) may affect blood sugar .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>vitamin C</keyword>
	<keyword>vitamin E</keyword>
</DOC>